Food and Drug Administration, serves as a critical pharmacovigilance tool for post-marketing surveillance of pharmaceutical products and therapeutic biologics 17
The main concern is overlapping digestive effects, especially nausea and diarrhea
GLP-1 medications do slow gastric emptying
Reduced Oxidative Stress: Neutralizes free radicals to lower overall cellular inflammation
Compounding may be appropriate when: A required dose, concentration, or formulation is not commercially available An FDA-approved drug is in a temporary shortage A patient has a documented allergy or intolerance to an inactive ingredient Compounding is intended to address medical necessity , not convenience, mass substitution, or price alone
While the potential benefits are impressive, GLP-1 medications aren't appropriate for everyone with sleep apnea